|
EP2342183A1
|
|
1,3 imidazolidine derivatives and their use in the production of carbapenem
|
|
EP2141167A1
|
|
Process for synthesizing carbapenem using raney nickel
|
|
EP2048240A2
|
|
Process for producing 7-methoxy-3-desacetylcefalotin
|
|
EP2030975A1
|
|
CEFDINIR synthesis process
|
|
EP1974721A1
|
|
Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles
|
|
EP1777228A1
|
|
Purification of béta-lactam products
|
|
US2007054889A1
|
|
Injectable sterile pharmaceutical formulation containing at least two active principles
|
|
CN1903806A
|
|
Method for preparing alkali metal salt and alkaline-earth metal salt of medicine
|
|
US2007027314A1
|
|
Process for preparing sodium cefoxitin
|
|
US2006281916A1
|
|
Process for obtaining cefotetan with high yield
|
|
US2006281915A1
|
|
Acid cefotetan totally solvent-free and method for obtaining same
|
|
EP1724273A1
|
|
Crystalline acetonitrile solvate of cefuroxime acid
|
|
US2006100424A1
|
|
Process for producing Cefepime and cephalosporin analogues
|
|
EP1529766A1
|
|
Process for fragmentation of fungal, bacterial or yeast cell DNA and for inactivating residual antibiotics in fermentation biomass
|
|
US2005119244A1
|
|
Process for preparing cephalosporins with salified intermediate
|
|
US2003204082A1
|
|
Crystalline form of cefdinir
|
|
CN1448132A
|
|
Modified antineoplastic preparation based on Paclitaxel
|
|
EP1348431A1
|
|
Process for producing nanoparticles of paclitaxel and albumin
|
|
EP1348430A1
|
|
Improved paclitaxel-based antitumor formulation
|
|
US2004002601A1
|
|
Method for producing cephalosporins
|
